Evidence map›Paper›PMID 34386511›Full record

ArticleFrontiers in medicine2021

Evidence-Based Selection on the Appropriate FIT Cut-Off Point in CRC Screening Programs in the COVID Pandemic.

Rocío Aznar-Gimeno, Patricia Carrera-Lasfuentes, Rafael Del-Hoyo-Alonso, Manuel Doblaré, Ángel Lanas

Abstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rocío Aznar-GimenoDepartment of Big Data and Cognitive Systems, Instituto Tecnológico de Aragón, ITAINNOVA, Zaragoza, Spain.
Patricia Carrera-LasfuentesBiomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd), Madrid, Spain.
Rafael Del-Hoyo-AlonsoDepartment of Big Data and Cognitive Systems, Instituto Tecnológico de Aragón, ITAINNOVA, Zaragoza, Spain.
Manuel DoblaréAragón Health Research Institute (IIS Aragón), Zaragoza, Spain.
Ángel LanasBiomedical Research Networking Center in Hepatic and Digestive Diseases (CIBERehd), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adenomascolonoscopycolorectal cancerdecision-makingscreening fecal-immunological test

Identifiers

PMID34386511
PMCPMC8353123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.